Home / Investors Information / EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences Read more about EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences EDAP Reports Third Quarter 2011 Financial Results Read more about EDAP Reports Third Quarter 2011 Financial Results EDAP Generates First U.S. Sonolith i-move Lithotripter Sale Read more about EDAP Generates First U.S. Sonolith i-move Lithotripter Sale EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results Read more about EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results EDAP Reports 61% Sequential Revenue Increase for Third Quarter 2011 Read more about EDAP Reports 61% Sequential Revenue Increase for Third Quarter 2011 EDAP Receives Sonolith i-move Approval in Russia Read more about EDAP Receives Sonolith i-move Approval in Russia EDAP to Present at Rodman & Renshaw Annual Global Investment Conference Read more about EDAP to Present at Rodman & Renshaw Annual Global Investment Conference EDAP Reports Second Quarter 2011 Financial Results Read more about EDAP Reports Second Quarter 2011 Financial Results EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer Read more about EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer EDAP Gains U.S. FDA 510(k) Lithotripter Clearance Read more about EDAP Gains U.S. FDA 510(k) Lithotripter Clearance Pagination First page « First Previous page ‹ Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Next page Next › Last page Last » Subscribe to
EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences Read more about EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences
EDAP Reports Third Quarter 2011 Financial Results Read more about EDAP Reports Third Quarter 2011 Financial Results
EDAP Generates First U.S. Sonolith i-move Lithotripter Sale Read more about EDAP Generates First U.S. Sonolith i-move Lithotripter Sale
EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results Read more about EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results
EDAP Reports 61% Sequential Revenue Increase for Third Quarter 2011 Read more about EDAP Reports 61% Sequential Revenue Increase for Third Quarter 2011
EDAP Receives Sonolith i-move Approval in Russia Read more about EDAP Receives Sonolith i-move Approval in Russia
EDAP to Present at Rodman & Renshaw Annual Global Investment Conference Read more about EDAP to Present at Rodman & Renshaw Annual Global Investment Conference
EDAP Reports Second Quarter 2011 Financial Results Read more about EDAP Reports Second Quarter 2011 Financial Results
EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer Read more about EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer
EDAP Gains U.S. FDA 510(k) Lithotripter Clearance Read more about EDAP Gains U.S. FDA 510(k) Lithotripter Clearance
